Proteina de union a il-17, construccion que comprende dicha proteina, un polipeptido ligador o un dominio constante de una inmunoglobulina; conjugado de dicha proteina; acido nucleico que la codifica; vector; celula huesped, metodo de produccion; composicion que la comprende; y su uso para reducir la actividad de la il-17 en una patologia en la cual il-17 es perjudicial (div.sol.2129-11)

Proteins capable of binding human IL-17 and TNF-± are described along with their use in composition and methods for treating, preventing, and diagnosing diseases related to IL- 17 and TNF-± related diseases and for detecting and/or TNF-± in cells, tissues, samples, and compositions.

Saved in:
Bibliographic Details
Main Authors MEMMOTT JOHN E, MCRAE BRADFORD L, CLABBERS ANCA, ZHONG SUJU, WALLACE CRAIG, KUTSKOVA YULIYA, BRYANT SHAUGHH H, HSIEH CHUNG-MING, MURTAZA ANWAR, LEDDY MARY R, PEREZ JENNIFER M, TARCSA EDIT, HUGUNIN MARGARET
Format Patent
LanguageSpanish
Published 25.07.2014
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Proteins capable of binding human IL-17 and TNF-± are described along with their use in composition and methods for treating, preventing, and diagnosing diseases related to IL- 17 and TNF-± related diseases and for detecting and/or TNF-± in cells, tissues, samples, and compositions.
Bibliography:Application Number: CL20130003640